School: Pennsylvania State University

Carla Bertulfo is a PhD candidate in Biological Sciences at Columbia University. For Carla’s doctoral studies, they are using the Nobel Prize-winning gene editing technology CRISPR to explore combinatorial therapies against T cell acute lymphoblastic leukemia.